Showing 1 - 7 results of 7 for search 'Johannes L. Bos', query time: 0.03s
Refine Results
-
1
Mechanisms of isoform specific Rap2 signaling during enterocytic brush border formation. by Lucas J M Bruurs, Johannes L Bos
Published 2014-01-01
Article -
2
-
3
Rap1 and Rap2 antagonistically control endothelial barrier resistance. by Willem-Jan Pannekoek, Jelena R Linnemann, Patricia M Brouwer, Johannes L Bos, Holger Rehmann
Published 2013-01-01
Article -
4
-
5
Structure-guided design of selective Epac1 and Epac2 agonists. by Frank Schwede, Daniela Bertinetti, Carianne N Langerijs, Michael A Hadders, Hans Wienk, Johanne H Ellenbroek, Eelco J P de Koning, Johannes L Bos, Friedrich W Herberg, Hans-Gottfried Genieser, Richard A J Janssen, Holger Rehmann
Published 2015-01-01
Article -
6
Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening by Carla S Verissimo, René M Overmeer, Bas Ponsioen, Jarno Drost, Sander Mertens, Ingrid Verlaan-Klink, Bastiaan van Gerwen, Marieke van der Ven, Marc van de Wetering, David A Egan, René Bernards, Hans Clevers, Johannes L Bos, Hugo J Snippert
Published 2016-11-01
Article -
7
Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer by Sander Mertens, Maarten A. Huismans, Carla S. Verissimo, Bas Ponsioen, Rene Overmeer, Natalie Proost, Olaf van Tellingen, Marieke van de Ven, Harry Begthel, Sylvia F. Boj, Hans Clevers, Jeanine M.L. Roodhart, Johannes L. Bos, Hugo J.G. Snippert
Published 2023-04-01
Article